How to conduct first in human clinical trials: An interview with Richmond’s CEO
European Pharmaceutical Review caught up with Richmond Pharmacology’s CEO, Dr Jorg Taubel, to talk pioneering UK based first-in-human clinical trials…
List view / Grid view
Articles
Partnering to fund clinical trials: A new model for pharma
21 April 2017 | By Ben van der Schaaf, Principal at Arthur D. Little
Ben van der Schaaf explains how collaborative work can fund clinical trials of de-prioristised drugs and why pharma should consider partnering up...
Strategic aspects of change control for pharmaceutical packaging systems
Plastic materials used in pharmaceutical packaging can interact with the packaged dosage form, causing leachables to accumulate...
The rush to rapid microbiological methods – or not
Guardino (2005) identified the first rapid microbiological method as a rapid plate count technique. This method was developed by Professor Frost...
GC-MS applications in pharmaceutical analysis
Gas chromatography (GC) predates the more commonly utilised high performance liquid chromatography (HPLC). However, GC continues to enjoy some important niche applications in modern pharmaceutical analysis, such as the analysis of residual solvents or volatile organic compounds (VOCs)...
Pharmaceutical QbD: Omnipresence in the product development lifecycle
The concept of Quality by Design (QbD) was implemented by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) and United States Food and Drug Administration (FDA) around a decade ago, with the aim of adopting systematic approaches for developing high-quality pharmaceutical products for patients’…
FMD and supply chain security
Over 12 months ago, the European Union delegated regulation that supplements the Falsified Medicines Directive (FMD) was published in the Official Journal of the European Union, starting the countdown to the deadline of 9 February 2019, when most EU member-states, and three non-members currently, are expected to have implemented all…
Integrated Health: Combining conventional healthcare with alternative medicine
Dr Rajendra Sharma argues the case for combining traditional healthcare with complementary and alternative medicine to create personal patient treatments...
Microbiological monitoring of pharmaceutical water systems
Water is widely used in pharmaceutical manufacturing – either as a raw material, as an ingredient, or as a final product. Water is also used for rinsing equipment or for the preparation of disinfectants and detergents...
Mass spectrometry in the development of protein biologics
Biological products, usually referred to as biologics, constitute a significant segment of pharmaceuticals in development. Biologics include therapeutic proteins, antibody drugs, antibody-drug conjugates (ADCs), vaccines, carbohydrates drugs, blood and tissue-derived pharmaceuticals, gene therapies, even live cells and tissues...
Endotoxin masking hold-time study performance parameters
Presented here are recommendations for performing an endotoxin masking hold-time study. The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have requested hold-time studies to determine the presence of what has been called ‘low endotoxin recovery’ (LER) for submission with biologic licence applications (BLA)...
Issue #2 2017 – Digital version
Read the free-to-view digital version of the latest issue of European Pharmaceutical Review...
Mass Spectrometry In-Depth Focus 2017
In this Mass Spectrometry In-Depth Focus: Mass spectrometry in the development of protein biologics; and GC-MS applications in pharmaceuticals analysis...
Microbiology In-Depth Focus 2017
In this Microbiology In-Depth Focus: Endotoxin masking hold-time study performance parameters; Microbiological monitoring pharmaceutical water systems; The rush to rapid microbiological methods - or not; and an expert view with Charles River Laboratories...
Why combatting cybercrime is critical for life science companies
Biotech and pharmaceutical firms hold vast amounts of valuable data and information making them prime targets for cyber-attacks – so how are they protecting themselves?
